1. Home
  2. SYRA vs BGLC Comparison

SYRA vs BGLC Comparison

Compare SYRA & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRA
  • BGLC
  • Stock Information
  • Founded
  • SYRA 2020
  • BGLC N/A
  • Country
  • SYRA United States
  • BGLC Malaysia
  • Employees
  • SYRA N/A
  • BGLC 30
  • Industry
  • SYRA Other Specialty Stores
  • BGLC Medical Specialities
  • Sector
  • SYRA Industrials
  • BGLC Health Care
  • Exchange
  • SYRA Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • SYRA 8.5M
  • BGLC 9.2M
  • IPO Year
  • SYRA 2023
  • BGLC N/A
  • Fundamental
  • Price
  • SYRA $1.33
  • BGLC $0.51
  • Analyst Decision
  • SYRA
  • BGLC
  • Analyst Count
  • SYRA 0
  • BGLC 0
  • Target Price
  • SYRA N/A
  • BGLC N/A
  • AVG Volume (30 Days)
  • SYRA 38.5K
  • BGLC N/A
  • Earning Date
  • SYRA 08-13-2024
  • BGLC N/A
  • Dividend Yield
  • SYRA N/A
  • BGLC N/A
  • EPS Growth
  • SYRA N/A
  • BGLC N/A
  • EPS
  • SYRA N/A
  • BGLC N/A
  • Revenue
  • SYRA $6,079,133.00
  • BGLC N/A
  • Revenue This Year
  • SYRA $70.86
  • BGLC N/A
  • Revenue Next Year
  • SYRA N/A
  • BGLC N/A
  • P/E Ratio
  • SYRA N/A
  • BGLC N/A
  • Revenue Growth
  • SYRA 3.73
  • BGLC N/A
  • 52 Week Low
  • SYRA $0.81
  • BGLC N/A
  • 52 Week High
  • SYRA $8.37
  • BGLC N/A
  • Technical
  • Relative Strength Index (RSI)
  • SYRA 46.61
  • BGLC 54.40
  • Support Level
  • SYRA $1.26
  • BGLC $0.46
  • Resistance Level
  • SYRA $1.37
  • BGLC $0.48
  • Average True Range (ATR)
  • SYRA 0.08
  • BGLC 0.03
  • MACD
  • SYRA -0.00
  • BGLC 0.01
  • Stochastic Oscillator
  • SYRA 47.06
  • BGLC 80.23

About SYRA Syra Health Corp.

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Share on Social Networks: